Catherine Pearce - Jan 11, 2023 Form 4 Insider Report for CinCor Pharma, Inc. (CINC)

Role: Chief Operating Officer
Signature: /s/ Cathy Rude, Attorney-in-Fact
Stock symbol: CINC
Transactions as of: Jan 11, 2023
Transactions value $: -$114,914
Form type: 4
Date filed: 1/19/2023, 03:34 PM
Previous filing: Jan 13, 2022
Next filing: Jan 30, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CINC	Common Stock	Options Exercise		+13.2K	+10.11%		144K	Jan 11, 2023	Direct	F1
transaction	CINC	Common Stock	Tax liability	-$115K	-4K	-2.77%	$28.75	140K	Jan 11, 2023	Direct
holding	CINC	Common Stock						1.5K	Jan 11, 2023	By spouse	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CINC	Restricted Stock Units	Options Exercise	$0	-13.2K	-50%	$0.00	13.2K	Jan 11, 2023	Common Stock	13.2K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
F2	The securities are held by the Reporting Person's spouse. The Reporting Person shares voting and investment control of the shares and may be deemed to beneficially own the shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of her proportionate pecuniary interest therein.
F3	The RSUs vest in two equal annual installments beginning January 11, 2023, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.